Enzyme immunoassay for Q fever: comparison with complement fixation and immunofluorescence tests and dot

R Cowley1, F Fernandez, W Freemantle

  • 1Division of Pathology, Centre for Applied Microbiology and Research, Salisbury, Wiltshire, United Kingdom.

Insights

New enzyme-linked immunosorbent assays (ELISA) offer a rapid and sensitive method for diagnosing Q fever. These tests, alongside enhanced immunofluorescence, show high agreement and are recommended replacements for the complement fixation test.

Area of Science:

  • Microbiology
  • Immunology
  • Infectious Diseases

Background:

  • Q fever is a significant zoonotic disease caused by Coxiella burnetii.
  • Current diagnostic methods like complement fixation (CF) have limitations, including anticomplementary activity in serum samples.

Purpose of the Study:

  • To develop and optimize enzyme-linked immunosorbent assays (ELISA) for detecting Coxiella burnetii specific IgG and IgM antibodies.
  • To compare the diagnostic performance of ELISA and enhanced immunofluorescence (EIF) with the traditional CF test.

Main Methods:

  • Purified Coxiella burnetii cells were used to develop IgG and IgM ELISAs.
  • Optimization involved evaluating microtiter plates, blocking agents, incubation conditions, antigen stability, and substrates.
  • Assay reliability was assessed using 600 human serum samples and compared against CF and EIF tests.

Main Results:

  • ELISA and EIF tests demonstrated complete agreement in all tested samples.
  • Dot immunoblotting provided rapid, qualitative results that also agreed with ELISA and EIF.
  • ELISA and EIF detected positive cases missed by CF, especially those with anticomplementary activity.

Conclusions:

  • ELISA and EIF are rapid, sensitive, and reliable serodiagnostic tests for Q fever.
  • Dot immunoblotting serves as an effective screening tool.
  • ELISA and EIF are recommended as superior replacements for the complement fixation test in Q fever diagnosis.